Uncategorized Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial 18 Jan 2023 Adaptive Phage Therapeutics, Inc., (APT) a clinical-stage biotechnology company advancing the APT phage bank, the world’s largest therapeutic phage initiative for treatment of bacterial infectious diseases, today announced the first…
PHAGElogist 